Synthesizing Mind-Sets for Participants Undergoing Clinical Trials — The Case of Weight Loss Drugs
Howard R Moskowitz, Sunaina Saharan, Stephen D Rappaport, Taylor Mulvey, Sharon Wingert, Tonya Anderson, and Martin Mulvey
The paper focuses on the synthesis of mind-sets for patients who are undergoing clinical trials with
weight-reducing drugs. The objective is to demonstrate how LLMs, large language models, can be
combined with Mind Genomics thinking to better understand how patients in these clinical trials may
think. Although the data are simulated, the outcome provides a way for the clinician and the drug
manufacturer, as well as the participating physician, to understand the deeper thoughts of the study
participants. As such, the approach is presented as a didactic tool to introduce the minds of patients as
people to clinicians and to drug companies, doing so in the same spirit as consumer researchers seek to
understand the corporation’s customers.
